Uncovering
the Need to Sleep:
Case Studies on Management of Restless Legs Syndrome
Release Date: December 7, 2007
Expiration Date: December 6, 2008
Activity
Goal
To raise the awareness of restless legs syndrome and available treatment
options.
Statement
of Need
Primary
restless legs syndrome (RLS) is a chronic, idiopathic, sensory disorder
occurring primarily at rest which is defined as symptoms of spontaneous,
continuous leg movements and associated unpleasant paresthesias, causing
an almost irresistible urge to move the legs. RLS can significantly
disrupt sleep, and, as a result, can lead to daytime fatigue, stress,
and mood disorders. Because of this, RLS can have a significant impact
upon patients enrolled in managed health care plans, and consequently
cause a measurable burden on the American health care system. Additionally,
patients with RLS can suffer from poor work performance and a reduction
in productivity, which can affect worker productivity and lead to increased
costs to employers. There are multiple treatments that can be used to
treat patients with RLS, including non-pharmacologic agents, benzodiazepines,
dopamine agonists, opioids, and gabapentin.
Intended
Audience
This activity has been designed to meet the educational needs of managed
care physicians, primary care physicians, physician assistants, nurse
practitioners, pharmacists, nurses, certified case managers, human resource
specialists and others involved in the care and management of patients
with restless legs syndrome.
Educational
Learning Objectives
At the conclusion of this activity, you will be able to:
- Differentiate restless legs syndrome (RLS) and its impact in managed
care and employer groups
- Identify diagnostic and guidelines criteria for RLS: NIH workshop
of the IRLS Study Group and RLS Foundation
- Discuss short- and long-term management strategies to improve productivity,
control co-morbidities and enhance quality of life for persons with
RLS through case-based learning
Accreditation
Statements
Physician Continuing Medical Education
 Professional
Resources In Management Education, Inc. (PRIME®) designates
this educational activity for a maximum of 1.0 AMA PRA Category 1
Credit™. Physicians should only claim credit commensurate with
the extent of their participation in the activity. AMA PRA Category 1
Credit is a trademark of the American Medical Association. PRIME®
is accredited by the Accreditation Council for Continuing Medical Education
to provide continuing medical education for physicians.
Family Physician Continuing Education
This activity has been reviewed and is acceptable for up to 1.00
Prescribed credit(s) by the American Academy of Family Physicians. AAFP
accreditation begins 12/07/07. The term of approval is for one-year from
this date, with option for yearly renewal.
Nurse Practitioner Continuing Education
 PRIME®
is approved as a provider of nurse practitioner continuing education by
the American Academy of Nurse Practitioners: AANP Provider Number 060815.
This activity has been approved for up to 1.2 contact hours of continuing
education which includes up to 0.75 hours of pharmacology.
Pharmacist Continuing Education
 This
curriculum has been approved for 1.0 contact hour(s) by PRIME®.
PRIME® is accredited by the Accreditation Council for
Pharmacy Education as a provider of continuing pharmacy education. The
ACPE Universal Program Number for this activity is 255-000-07-026-H01.
Nursing Continuing Education
PRIME® designates this educational activity for up to
1.2 contact hours by the Florida Board of Nursing and the California Board
of Registered Nursing.
Case Manager Continuing Education
The Commission of Case Manager Certification has approved this educational
activity for 1.0 contact hour(s) for certified case managers through PRIME®.
Human Resource Specialist Accreditation Statement
 This
program is accredited for 1.0 recertification credit hours toward PHR,
SPHR and GPHR recertification through the Human Resource Certification
Institute (HRCI). For more information about certification or recertification,
please visit the HRCI homepage at www.hrci.org.
Faculty
Richard
P. Allen, PhD
(Click on faculty name to view biography)
Diplomate American Board of Sleep Medicine
Research Associate
Department of Neurology
Johns Hopkins University
Baltimore, MD
Dr. Allen admits to no disclosures. Dr. Allen will be receiving an honorarium
for this presentation.
PRIME® Disclosure
Statement
PRIME® holds the standard that its continuing medical
education programs be free of commercial bias. The faculty have been asked
to disclose any relationship they have with companies producing pharmaceuticals,
medical equipment, etc., that might be germane to their contribution(s)
to this program or any relationship they may have with the commercial
supporter of the program. These disclosures are not intended to suggest
or condone bias but are elicited to provide participants with information
that might be of potential importance in their evaluation of the program.
The faculty reported receiving something of value from a company whose
product may be germane to the program content. Something of value refers
to an equity position, vested interest, receipt of royalties, consultantship,
funding by a research grant, honoraria, received for educational services,
or any other relationship to a company that provides sufficient reason
for disclosure. Please refer to the individual faculty biographies for
individual disclosure information. The material presented here does not
imply endorsement by PRIME®, the ACCME, the ACPE, the
ANCC or other accreditation bodies through which PRIME sponsors educational
programming. These materials may discuss therapeutic products that have
not been approved by the US Food and Drug Administration and off-label
uses of approved products. A qualified healthcare professional should
be consulted before using any therapeutic product discussed. Readers should
verify all information and data before treating patients or employing
any therapies described in this educational activity.
Resolution of Conflict of Interest
PRIME® uses a comprehensive review process to resolve
conflict of interest, including content validation, an internal quality
assurance set of procedures, and an external peer review process.
Instructions
To receive a certificate of completion that indicates your eligibility
for continuing education credit, you must:
- Review the full content of the activity.
- Successfully complete the post-test (Score 70% or higher).
- You will have two opportunities to successfully complete the activity.
Your certificate of completion will be issued immediately upon successful
completion of the post-test and submission of the evaluation.
Fee
There is no fee for this activity.
Program content was peer reviewed to ensure that it is fair-balanced and
free from bias.
Commercial
Support
This activity is supported through an unrestricted educational grant
from Boehringer Ingelheim Pharmaceuticals, Inc.
Software
Requirements:
If you have questions regarding the program, feel free to call 954-718-6055.
|
